Background Polyendocrine metabolic ovarian syndrome (PMOS) is a common endocrine disorder affecting 5% to 15% of reproductive-aged individuals and is frequently accompanied by hype
This is a narrative review synthesizing applications of CRISPR-Cas systems in animal CVD models; it raises questions about translational potential rather than testing clinical hypotheses or reporting primary research findings.